Anna Wiela-Hojeńska

9PUBLICATIONS
9CO-AUTHORS
Nanotoxicology, health and safetyMetabolic medicineGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 24, 2026
Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real-World Analysis of WHO Pharmacovigilance Data.

|Apr 14, 2026
Primary, Secondary and Exploratory Endpoints in Phase 2 and 3 Clinical Trials with Novel Therapies in MASH Cirrhosis: A Systematic Review.

Grzegorz Żurakowski, Anna Wiela-Hojeńska, Paweł Petryszyn

|Dec 30, 2025
The Diagnostic Reliability of BIN1 and TOMM40 Genotyping in Assessing Dementia Risk.

Marta Machowska, Jerzy Leszek, Aleksandra Mikołajczyk-Tarnawa

|Nov 13, 2025
ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia.

Marta Machowska, Jerzy Leszek, Maja Rączy-Krzemianowska

|Sep 09, 2023
The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression.

Julian Maciaszek, Tomasz Pawłowski, Tomasz Hadryś

|Mar 11, 2023
Over the Counter Pain Medications Used by Adults: A Need for Pharmacist Intervention.

Katarzyna Karłowicz-Bodalska, Natalia Sauer, Laura Jonderko

Pageof 2

Frequent Collaborators

2 joint publications

Katarzyna Karłowicz-Bodalska

2 joint publications

Natalia Sauer

2 joint publications

Małgorzata Rąpała

1 joint publications

Magdalena Hurkacz